Claudia Alpini

Medicine & Life Sciences

1. Anti-Citrullinated Protein Antibodies 100%
2. Rheumatoid Arthritis 89%
3. Rheumatic Diseases 73%
4. citrullinated-eBNA-2 protein (338-358) 65%
5. Antibodies 64%
6. Pregnancy Outcome 60%
7. Rheumatoid Factor 60%
8. Connective Tissue Diseases 57%
9. First Pregnancy Trimester 56%
10. Systemic Scleroderma 51%
11. Autoantibodies 49%
12. cyclic citrullinated peptide 48%
13. Tankyrases 45%
14. Antisynthetase syndrome 43%
15. fibrillarin 43%
16. Undifferentiated Connective Tissue Diseases 43%
17. Arthritis 39%
18. Autoimmune Diseases 36%
19. Tumor Necrosis Factor Inhibitors 34%
20. Fetal Growth Retardation 34%
21. Anti-Idiotypic Antibodies 33%
22. Pre-Eclampsia 33%
23. RNA Polymerase III 30%
24. Cohort Studies 30%
25. Rose Bengal acetate 30%
26. Type I DNA Topoisomerase 29%
27. Undiagnosed Diseases 29%
28. Fluorescent Antibody Technique 28%
29. Indirect Fluorescent Antibody Technique 28%
30. Antinuclear Antibodies 26%
31. human MYC protein 26%
32. HeLa Cells 24%
33. Mortality 23%
34. Interstitial Lung Diseases 23%
35. Antiphospholipid Syndrome 22%
36. Pregnancy 22%
37. Thyroid Gland 22%
38. Infliximab 21%
39. Immunoglobulin A 21%
40. Pregnancy Complications 21%
41. Differential Diagnosis 20%
42. HLA-G Antigens 19%
43. Photosensitivity Disorders 19%
44. Joints 18%
45. Peptides 18%
46. Poly (ADP-Ribose) Polymerase-1 18%
47. Mitochondria 18%
48. Lysosomes 18%
49. Enzyme-Linked Immunosorbent Assay 17%
50. Apoptosis 17%